Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1947 1
1951 2
1952 3
1953 3
1954 1
1955 5
1956 2
1957 5
1958 5
1959 2
1960 3
1961 4
1962 3
1963 6
1964 8
1965 11
1966 6
1967 13
1968 12
1969 19
1970 26
1971 18
1972 30
1973 42
1974 39
1975 44
1976 32
1977 46
1978 43
1979 40
1980 52
1981 34
1982 37
1983 34
1984 31
1985 35
1986 26
1987 35
1988 37
1989 36
1990 43
1991 34
1992 29
1993 31
1994 42
1995 47
1996 45
1997 41
1998 36
1999 43
2000 57
2001 93
2002 116
2003 129
2004 133
2005 145
2006 238
2007 203
2008 177
2009 203
2010 225
2011 202
2012 225
2013 238
2014 208
2015 240
2016 253
2017 275
2018 275
2019 324
2020 334
2021 267
Text availability
Article attribute
Article type
Publication date

Search Results

5,241 results
Results by year
Filters applied: . Clear all
Page 1
A Review of Fabry Disease.
Chan B, Adam DN. Chan B, et al. Skin Therapy Lett. 2018 Mar;23(2):4-6. Skin Therapy Lett. 2018. PMID: 29562089 Free article. Review.
Fabry disease (FD) is an X-linked lysosomal storage disease. A lack of alpha-galactosidase activity results in the accumulation of globotriaosylceramide in cells of various systems, leading to multi-systemic effects. ...
Fabry disease (FD) is an X-linked lysosomal storage disease. A lack of alpha-galactosidase activity results in the accu
Fabry disease.
Schiffmann R. Schiffmann R. Handb Clin Neurol. 2015;132:231-48. doi: 10.1016/B978-0-444-62702-5.00017-2. Handb Clin Neurol. 2015. PMID: 26564084 Review.
Specific therapy for Fabry disease has been developed in the last few years but its role in the management of the disorder is still being investigated. Fortunately, standard 'non-specific' medical and surgical therapy is effective in slowing deterioration or compens …
Specific therapy for Fabry disease has been developed in the last few years but its role in the management of the disorder is …
Fabry's disease--a comprehensive review on pathogenesis, diagnosis and treatment.
Mahmud HM. Mahmud HM. J Pak Med Assoc. 2014 Feb;64(2):189-94. J Pak Med Assoc. 2014. PMID: 24640811 Free article. Review.
Fabry's is a progressive, destructive and life threatening disease which reduces significantly life expectancy of the affected individual. ...Specific therapy for Fabry's disease is enzyme replacement with recombinant human alpha-galactosidase A. ...
Fabry's is a progressive, destructive and life threatening disease which reduces significantly life expectancy of the affected
Fabry's disease.
El-Abassi R, Singhal D, England JD. El-Abassi R, et al. J Neurol Sci. 2014 Sep 15;344(1-2):5-19. doi: 10.1016/j.jns.2014.06.029. Epub 2014 Jun 21. J Neurol Sci. 2014. PMID: 25106696 Review.
Fabry's disease is an X-linked lysosomal storage disorder caused by abnormalities in the GLA gene, which leads to a deficiency in alpha-galactosidase A. ...This review aims to raise the awareness of the signs and symptoms of Fabry's disease as well as
Fabry's disease is an X-linked lysosomal storage disorder caused by abnormalities in the GLA gene, which leads to a deficiency
Fabry disease: where are we now?
Turkmen K, Baloglu I. Turkmen K, et al. Int Urol Nephrol. 2020 Nov;52(11):2113-2122. doi: 10.1007/s11255-020-02546-3. Epub 2020 Jul 13. Int Urol Nephrol. 2020. PMID: 32661622 Review.
Fabry disease (FD) is a multisystemic X-linked disorder characterized by the accumulation of lysosomal globotriaosylceramide (Gb3) secondary to decreased activity of alpha-galactosidase in cells. Generally, males are more severely affected due to the X-linked inheri
Fabry disease (FD) is a multisystemic X-linked disorder characterized by the accumulation of lysosomal globotriaosylceramide (
Fabry disease: genetics, pathology, and treatment.
Bernardes TP, Foresto RD, Kirsztajn GM. Bernardes TP, et al. Rev Assoc Med Bras (1992). 2020 Jan 13;66Suppl 1(Suppl 1):s10-s16. doi: 10.1590/1806-9282.66.S1.10. Rev Assoc Med Bras (1992). 2020. PMID: 31939530 Free article. Review.
Fabry disease (FD) is a recessive monogenic inheritance disease linked to chromosome X, secondary to mutations in the GLA gene. ...It is considered that the specific treatment should be initiated as soon as a diagnosis is obtained, which can change the progno
Fabry disease (FD) is a recessive monogenic inheritance disease linked to chromosome X, secondary to mutations in the G
When and How to Diagnose Fabry Disease in Clinical Pratice.
Michaud M, Mauhin W, Belmatoug N, Garnotel R, Bedreddine N, Catros F, Ancellin S, Lidove O, Gaches F. Michaud M, et al. Am J Med Sci. 2020 Dec;360(6):641-649. doi: 10.1016/j.amjms.2020.07.011. Epub 2020 Jul 10. Am J Med Sci. 2020. PMID: 32723516 Review.
Fabry disease may present as "classical", as "late-onset" or "non-classical" forms. ...In this review, we aimed to summarize main clinical manifestations of Fabry disease to know when to evoke Fabry disease and propose a practical diagnos
Fabry disease may present as "classical", as "late-onset" or "non-classical" forms. ...In this review, we aimed to summarize m
Fabry's disease.
Zarate YA, Hopkin RJ. Zarate YA, et al. Lancet. 2008 Oct 18;372(9647):1427-35. doi: 10.1016/S0140-6736(08)61589-5. Lancet. 2008. PMID: 18940466 Review.
Fabry's disease is an X-linked lysosomal storage disorder caused by abnormalities in the GLA gene, which leads to a deficiency in alpha-galactosidase A. The consequent abnormal accumulation of glycosphingolipids results in several clinical signs and symptoms and sub
Fabry's disease is an X-linked lysosomal storage disorder caused by abnormalities in the GLA gene, which leads to a deficiency
Biomarkers in Anderson-Fabry Disease.
Simonetta I, Tuttolomondo A, Daidone M, Pinto A. Simonetta I, et al. Int J Mol Sci. 2020 Oct 29;21(21):8080. doi: 10.3390/ijms21218080. Int J Mol Sci. 2020. PMID: 33138098 Free PMC article. Review.
Fabry disease is a rare lysosomal storage disorder caused by a deficiency of alpha-galactosidase A, resulting in multisystemic involvement. ...The management of Fabry disease may be improved by the identification of biomarkers that reflect clinical cou
Fabry disease is a rare lysosomal storage disorder caused by a deficiency of alpha-galactosidase A, resulting in multisystemic
Anderson-Fabry disease.
Di Toro A, Favalli V, Arbustini E. Di Toro A, et al. J Cardiovasc Med (Hagerstown). 2018 Feb;19 Suppl 1:e1-e5. doi: 10.2459/JCM.0000000000000637. J Cardiovasc Med (Hagerstown). 2018. PMID: 29538136 Review. No abstract available.
5,241 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page